269 related articles for article (PubMed ID: 33619588)
1. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A
Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588
[TBL] [Abstract][Full Text] [Related]
2. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A
Acta Neuropathol; 2020 Feb; 139(2):223-241. PubMed ID: 31820118
[TBL] [Abstract][Full Text] [Related]
3. Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
Vasiljevic A
Childs Nerv Syst; 2023 Sep; 39(9):2273-2284. PubMed ID: 35972537
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
Liu APY; Gudenas B; Lin T; Orr BA; Klimo P; Kumar R; Bouffet E; Gururangan S; Crawford JR; Kellie SJ; Chintagumpala M; Fisher MJ; Bowers DC; Hassall T; Indelicato DJ; Onar-Thomas A; Ellison DW; Boop FA; Merchant TE; Robinson GW; Northcott PA; Gajjar A
Acta Neuropathol; 2020 Feb; 139(2):259-271. PubMed ID: 31802236
[TBL] [Abstract][Full Text] [Related]
5. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.
Pfaff E; Aichmüller C; Sill M; Stichel D; Snuderl M; Karajannis MA; Schuhmann MU; Schittenhelm J; Hasselblatt M; Thomas C; Korshunov A; Rhizova M; Wittmann A; Kaufhold A; Iskar M; Ketteler P; Lohmann D; Orr BA; Ellison DW; von Hoff K; Mynarek M; Rutkowski S; Sahm F; von Deimling A; Lichter P; Kool M; Zapatka M; Pfister SM; Jones DTW
Acta Neuropathol; 2020 Feb; 139(2):243-257. PubMed ID: 31768671
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.
Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S
World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
[TBL] [Abstract][Full Text] [Related]
8. Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.
Rahmanzade R; Pfaff E; Banan R; Sievers P; Suwala AK; Hinz F; Bogumil H; Cherkezov A; Kaan AF; Schrimpf D; Friedel D; Göbel K; Keller F; Saenz-Sardà X; Lossos A; Sill M; Witt O; Sakowitz OW; Korshunov A; Reuss DE; Etminan N; Unterberg A; Ratliff M; Herold-Mende C; Wick W; Pfister SM; von Deimling A; Jones DTW; Sahm F
Acta Neuropathol; 2023 Dec; 146(6):853-856. PubMed ID: 37776353
[No Abstract] [Full Text] [Related]
9. Pineal parenchymal tumors--utility of immunohistochemical markers in prognostication.
Arivazhagan A; Anandh B; Santosh V; Chandramouli BA
Clin Neuropathol; 2008; 27(5):325-33. PubMed ID: 18808064
[TBL] [Abstract][Full Text] [Related]
10. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
Lee JC; Mazor T; Lao R; Wan E; Diallo AB; Hill NS; Thangaraj N; Wendelsdorf K; Samuel D; Kline CN; Banerjee A; Auguste K; Raffel C; Gupta N; Berger M; Raleigh DR; Shai A; Phillips JJ; Bollen AW; Tihan T; Perry A; Costello J; Solomon DA
Acta Neuropathol; 2019 May; 137(5):851-854. PubMed ID: 30877433
[No Abstract] [Full Text] [Related]
11. Pineal parenchymal tumours and pineal cysts.
Jouvet A; Vasiljevic A; Champier J; Fèvre Montange M
Neurochirurgie; 2015; 61(2-3):123-9. PubMed ID: 24975206
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
Yamashita S; Takeshima H; Hata N; Uchida H; Shinojima N; Yokogami K; Nakano Y; Sakata K; Fudaba H; Enomoto T; Nakahara Y; Ujifuku K; Sugawara K; Iwaki T; Sangatsuda Y; Yoshimoto K; Hanaya R; Mukasa A; Suzuki K; Yamamoto J; Negoto T; Nakamura H; Momii Y; Fujiki M; Abe H; Masuoka J; Abe T; Matsuo T; Ishiuchi S;
J Neurooncol; 2023 Apr; 162(2):425-433. PubMed ID: 37052748
[TBL] [Abstract][Full Text] [Related]
13. Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors.
Uchida E; Sasaki A; Shirahata M; Suzuki T; Adachi JI; Mishima K; Yasuda M; Fujimaki T; Ichimura K; Nishikawa R
Brain Tumor Pathol; 2022 Jul; 39(3):130-138. PubMed ID: 35000018
[TBL] [Abstract][Full Text] [Related]
14. Pineal parenchymal tumors of intermediate differentiation: in need of a stringent definition to avoid confusion. Scientific commentary on 'Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics'.
Vasiljevic A
Acta Neuropathol; 2024 Feb; 147(1):34. PubMed ID: 38340187
[No Abstract] [Full Text] [Related]
15. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience.
Stoiber EM; Schaible B; Herfarth K; Schulz-Ertner D; Huber PE; Debus J; Oertel S
Radiat Oncol; 2010 Dec; 5():122. PubMed ID: 21184689
[TBL] [Abstract][Full Text] [Related]
16. Primary pineal tumors - Unraveling histological challenges and certain clinical myths.
Verma A; Epari S; Bakiratharajan D; Sahay A; Goel N; Chinnaswamy G; Shetty P; Moiyadi A; Goel A; Gupta T; Jalali R
Neurol India; 2019; 67(2):491-502. PubMed ID: 31085866
[TBL] [Abstract][Full Text] [Related]
17. Comparative genomic hybridization in pineal parenchymal tumors.
Rickert CH; Simon R; Bergmann M; Dockhorn-Dworniczak B; Paulus W
Genes Chromosomes Cancer; 2001 Jan; 30(1):99-104. PubMed ID: 11107183
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of tumors of the pineal region.
Fèvre-Montange M; Vasiljevic A; Champier J; Jouvet A
Future Oncol; 2010 May; 6(5):791-809. PubMed ID: 20465391
[TBL] [Abstract][Full Text] [Related]
19. Pineal parenchymal tumours of intermediate differentiation - An evidence-based review of a new pathological entity.
Amato-Watkins AC; Lammie A; Hayhurst C; Leach P
Br J Neurosurg; 2016; 30(1):11-5. PubMed ID: 26571134
[TBL] [Abstract][Full Text] [Related]
20. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.
Lu VM; Luther EM; Eichberg DG; Morell AA; Shah AH; Komotar RJ; Ivan ME
J Neurooncol; 2021 Nov; 155(2):165-172. PubMed ID: 34606044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
